Watch Ticker

Iterum Therapeutics plc Ordinary Share

Go to Iterum Therapeutics plc Ordinary Share Website

$0.70

0.00 (0.66%)

Live

Previous Close

$0.7

Day Range

$0.6573 - $0.718

Previous Day Range

$0.693 - $0.76

Market Cap

$29.5 million USD

Day Vol.

1.2 million

Previous Day Vol.

1.7 million

Currency

USD

Primary Exchange

Nasdaq

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem availabl...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - ITRM Reports Results

Iterum Therapeutics reported a Q2 2025 loss of $0.13 per share, higher than expected, as the company prepares for the commercial launch of its oral antibiotic ORLYNVAH™ for urinary tract infections. The company has secured manufacturing agreements and extended its cash runway into 2026.

Related tickers: ITRM, PFE, GSK.

Read Full Article

Iterum Therapeutics Plc - Iterum Therapeutics Reports Second Quarter 2025 Financial Results

Iterum Therapeutics plans to launch ORLYNVAH™, its first branded antibiotic for uncomplicated urinary tract infections, in August 2025. The company has partnered with EVERSANA for commercialization and has sufficient cash runway into 2026.

Related tickers: ITRM, PFE.

Read Full Article

Trending Tickers

Please sign in to view